Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea · Delayed Price · Currency is KRW 21,350
-650 (-2.95%)
At close: Oct 22, 2026
Aimed Bio Market Cap
Aimed Bio has a market cap or net worth of 1.38 trillion as of October 22, 2026. It is the 9,740th most valuable company in the world and the 249th biggest in South Korea.
Market Cap
1.38T
Enterprise Value
1.29T
Revenue
66.79B
Global Rank
Country Rank
#249 South Korea
PE Ratio
36.24
ChartMarket Cap Chart
Since December 4, 2025, Aimed Bio's market cap has decreased from 2.82T to 1.38T, a decrease of -51.09%. That is a compound annual growth rate of -55.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 1.38T | -62.64% |
| Dec 30, 2025 | 3.70T | 30.91% |
| Dec 4, 2025 | 2.82T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qurient | 881.37B |
| Rznomics | 699.48B |
| JS Link | 659.61B |
| ROKIT Healthcare | 388.96B |
| AprilBio | 371.38B |
| Curocell | 363.17B |
| Inventage Lab | 348.66B |
| HansBiomed | 264.98B |